A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients

被引：20
作者：
Phelan, Maria
Cook, Catherine
机构：
[1] Harm Reduction International,
来源：
BMC INFECTIOUS DISEASES | 2014年 / 14卷
关键词：
INJECT DRUGS; PEOPLE;
D O I：
10.1186/1471-2334-14-S6-S5
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 29 条
  • [1] Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons
    Alvarez, D.
    Dieterich, D. T.
    Brau, N.
    Moorehead, L.
    Ball, L.
    Sulkowski, M. S.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) : 683 - 689
  • [2] [Anonymous], EXP ACC COM IN PRESS
  • [3] [Anonymous], 2014, Global status report on noncommunicable diseases 2014
  • [4] [Anonymous], EUR COMM GR IN PRESS
  • [5] [Anonymous], GIL ATT SEC IN PRESS
  • [6] Bosely S, 2014, GUARDIAN NEWSPAPER
  • [7] Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis
    Dimova, Rositsa B.
    Zeremski, Marija
    Jacobson, Ira M.
    Hagan, Holly
    Des Jarlais, Don C.
    Talal, Andrew H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (06) : 806 - 816
  • [8] Esmat G, 2013, E MEDITERRANEAN HLTH, V19
  • [9] Eurasian Harm Reduction Network, 2013, QUIT WHIL NOT AH GLO
  • [10] Everson G, 2014, P 21 C RETR OPP INF
123